Antibody Prevalence to Canine Distemper Virus (CDV) in Stray Dogs in Turkey
World Small Animal Veterinary Association World Congress Proceedings, 2004
A. Gengay1, T. Oncel2,T. Karaiglu3, A.A. Sancak4. A.B. Demir3, A. Ozkul3
1Faculty of Veterinary Medicine, Department of Microbiology, Erciyes University, Kayseri, Turkey; 2Pfizer Animal Health, Ortakoy, Istanbul, Turkey; 3Faculty of Veterinary Medicine, Department of Virology, Ankara University, Ankara, Turkey; 4Faculty of Veterinary Medicine, Department of Internal Medicine, Ankara University, Ankara, Turkey

In this study, serum samples were collected from 609 clinically healthy stray dogs in the Ankara, Mugla and Istanbul provinces in Turkey between 2000 and 2002.

Dog sera were tested for the presence of canine distemper virus (CDV) neutralizing antibodies using Virus Neutralization assay (VNA) (1, 2).

The prevalence of antibodies in animals against CDV was found to be 9.03% (n=55) in 1/2 dilution. It was determined that the antibody titers of positive sera were ranged between 1/2 and1/32.

This result suggested that the stray dogs are potential source of CDV infections for susceptible animals living in an urban environment in Turkey.

References

1.  Appel M. J. G., Robson D.S. A microneutralization test for canine distemper virus. Am. J. Vet. Res., 1973, 34, 1459-1463.

2.  FrÖLich, K. et. al Epizootiological investigations of canine distemper virus in free-ranging carnivores from Germany. Vet. Microbiol., 2000, 74, 283-292.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

T. Oncel
Pfizer Animal Health
Ortakoy, Istanbul, Turkey


MAIN : Abstracts : Antibody Prevalence to CDV
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.

CONTACT US

777 W. Covell Blvd., Davis, CA 95616

vingram@vin.com

PHONE

  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357
SAID=27